197 related articles for article (PubMed ID: 23677249)
1. Desmopressin melt improves response and compliance compared with tablet in treatment of primary monosymptomatic nocturnal enuresis.
Juul KV; Van Herzeele C; De Bruyne P; Goble S; Walle JV; Nørgaard JP
Eur J Pediatr; 2013 Sep; 172(9):1235-42. PubMed ID: 23677249
[TBL] [Abstract][Full Text] [Related]
2. A randomised comparison of oral desmopressin lyophilisate (MELT) and tablet formulations in children and adolescents with primary nocturnal enuresis.
Lottmann H; Froeling F; Alloussi S; El-Radhi AS; Rittig S; Riis A; Persson BE
Int J Clin Pract; 2007 Sep; 61(9):1454-60. PubMed ID: 17655682
[TBL] [Abstract][Full Text] [Related]
3. Is there still a role for desmopressin in children with primary monosymptomatic nocturnal enuresis?: a focus on safety issues.
Van de Walle J; Van Herzeele C; Raes A
Drug Saf; 2010 Apr; 33(4):261-71. PubMed ID: 20297859
[TBL] [Abstract][Full Text] [Related]
4. Pharmacokinetics of desmopressin administered as tablet and oral lyophilisate formulation in children with monosymptomatic nocturnal enuresis.
De Bruyne P; De Guchtenaere A; Van Herzeele C; Raes A; Dehoorne J; Hoebeke P; Van Laecke E; Vande Walle J
Eur J Pediatr; 2014 Feb; 173(2):223-8. PubMed ID: 23989967
[TBL] [Abstract][Full Text] [Related]
5. Claiming desmopressin therapeutic equivalence in children requires pediatric data: a population PKPD analysis.
Michelet R; Dossche L; Van Herzeele C; Van Bocxlaer J; Vermeulen A; Vande Walle J;
Eur J Clin Pharmacol; 2018 Mar; 74(3):297-305. PubMed ID: 29198064
[TBL] [Abstract][Full Text] [Related]
6. [Comparison of two sublingual types of desmopressin in 6-year-old and more children with primary nocturnal enuresis. About an international randomized cross-over study].
Lottmann H
Prog Urol; 2009 Feb; 19(2):132-8. PubMed ID: 19168019
[TBL] [Abstract][Full Text] [Related]
7. Comparison of long-term efficacy of desmopressin lyophilisate and enuretic alarm for monosymptomatic enuresis and assessment of predictive factors for success: a randomized prospective trial.
Önol FF; Guzel R; Tahra A; Kaya C; Boylu U
J Urol; 2015 Feb; 193(2):655-61. PubMed ID: 25158273
[TBL] [Abstract][Full Text] [Related]
8. [Desmopressin in the Treatment of Enuresis: Is Lyophilisate Superior to Tablets?].
Schulz-Jürgensen S; Feldmann B; Eggert P
Aktuelle Urol; 2016 Dec; 47(6):480-486. PubMed ID: 28006831
[No Abstract] [Full Text] [Related]
9. Focus on desmopressin and enuresis: a review of literature.
Ferrara P; Vena F; Basile MC; Ianniello F; Gatto A
Minerva Urol Nefrol; 2016 Feb; 68(1):14-9. PubMed ID: 24990391
[TBL] [Abstract][Full Text] [Related]
10. Predictive parameters of response to desmopressin in primary nocturnal enuresis.
Van Herzeele C; Evans J; Eggert P; Lottmann H; Norgaard JP; Vande Walle J
J Pediatr Urol; 2015 Aug; 11(4):200.e1-8. PubMed ID: 26059526
[TBL] [Abstract][Full Text] [Related]
11. Evaluation of Urinary Aquaporin 2 and Plasma Copeptin as Biomarkers of Effectiveness of Desmopressin Acetate for the Treatment of Monosymptomatic Nocturnal Enuresis.
Hara T; Ohtomo Y; Endo A; Niijima S; Yasui M; Shimizu T
J Urol; 2017 Oct; 198(4):921-927. PubMed ID: 28457803
[TBL] [Abstract][Full Text] [Related]
12. Oral lyophylizate formulation of desmopressin: superior pharmacodynamics compared to tablet due to low food interaction.
De Guchtenaere A; Van Herzeele C; Raes A; Dehoorne J; Hoebeke P; Van Laecke E; Vande Walle J
J Urol; 2011 Jun; 185(6):2308-13. PubMed ID: 21511277
[TBL] [Abstract][Full Text] [Related]
13. Increased renal concentrating ability after long-term oral desmopressin lyophilisate treatment contributes to continued success for monosymptomatic nocturnal enuresis.
Ikeda H; Watanabe T; Isoyama K
Int J Urol; 2017 Sep; 24(9):698-702. PubMed ID: 28636262
[TBL] [Abstract][Full Text] [Related]
14. Optimizing response to desmopressin in patients with monosymptomatic nocturnal enuresis.
Kamperis K; Van Herzeele C; Rittig S; Vande Walle J
Pediatr Nephrol; 2017 Feb; 32(2):217-226. PubMed ID: 27071997
[TBL] [Abstract][Full Text] [Related]
15. Effect of desmopressin lyophilisate (MELT) plus anticholinergics combination on functional bladder capacity and therapeutic outcome as the first-line treatment for primary monosymptomatic nocturnal enuresis: A randomized clinical trial.
Shim M; Bang WJ; Oh CY; Kang MJ; Cho JS
Investig Clin Urol; 2021 May; 62(3):331-339. PubMed ID: 33834643
[TBL] [Abstract][Full Text] [Related]
16. Reduced anti-diuretic response to desmopressin during wet nights in patients with monosymptomatic nocturnal enuresis.
Tauris LH; Andersen RF; Kamperis K; Hagstroem S; Rittig S
J Pediatr Urol; 2012 Jun; 8(3):285-90. PubMed ID: 21514237
[TBL] [Abstract][Full Text] [Related]
17. 'Frequently recurring' nocturnal polyuria is predictive of response to desmopressin in monosymptomatic nocturnal enuresis in childhood.
Marzuillo P; Marotta R; Guarino S; Fedele MC; Palladino F; Capalbo D; Della Vecchia N; Miraglia Del Giudice E; Polito C; La Manna A
J Pediatr Urol; 2019 Apr; 15(2):166.e1-166.e7. PubMed ID: 30528650
[TBL] [Abstract][Full Text] [Related]
18. Poor compliance with primary nocturnal enuresis therapy may contribute to insufficient desmopressin response.
Van Herzeele C; Alova I; Evans J; Eggert P; Lottmann H; Nørgaard JP; Vande Walle J
J Urol; 2009 Oct; 182(4 Suppl):2045-9. PubMed ID: 19695639
[TBL] [Abstract][Full Text] [Related]
19. Safety profile of desmopressin tablet for enuresis in a prospective study.
Van Herzeele C; De Bruyne P; Evans J; Eggert P; Lottmann H; Norgaard JP; Vande Walle J
Adv Ther; 2014 Dec; 31(12):1306-16. PubMed ID: 25504157
[TBL] [Abstract][Full Text] [Related]
20. Desmopressin response in nocturnal enuresis showing concentrated urine.
Akagawa S; Tsuji S; Akagawa Y; Yamanouchi S; Kimata T; Kaneko K
Pediatr Int; 2020 Jun; 62(6):701-704. PubMed ID: 32065484
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
